VERITAS IN SILICO
Veritas In Silico is a start-up to research and sales of pharmaceuticals.Veritas In Silico, target partial structures in messenger RNA (mRNA) by exploring the true form of RNA, the origin of life, based on in silico (computer-based computational science) technology Established a drug discovery system with a completely new concept.This mRNA-targeted drug has the potential to be applied to any disease, including those for which it has been difficult to develop therapeutic drugs using conventional protein-based drug discovery. Therefore, it is expected to be a favorite for next-generation drug discovery that will cause a paradigm shift in the pharmaceutical industry.
VERITAS IN SILICO
Social Links:
Industry:
Business Information Systems Cloud Data Services Pharmaceutical
Founded:
2016-11-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.veritasinsilico.com
Total Employee:
11+
Status:
Active
Total Funding:
1.33 B JPY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics LetsEncrypt SSL By Default
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Yaoshibang
Yaoshibang is a Chinese B2B pharmaceutical trading platform.
Current Employees Featured
Founder
Investors List
Global Brain Corporation
Global Brain Corporation investment in Series C - Veritas In Silico
KDDI Open Innovation Fund
KDDI Open Innovation Fund investment in Series C - Veritas In Silico
SMBC Venture Capital
SMBC Venture Capital investment in Series B - Veritas In Silico
Shinsei Capital Partners
Shinsei Capital Partners investment in Series B - Veritas In Silico
Mitsubishi Gas Chemical
Mitsubishi Gas Chemical investment in Series B - Veritas In Silico
Mizuho Capital
Mizuho Capital investment in Series B - Veritas In Silico
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series B - Veritas In Silico
Nippon Venture Capital
Nippon Venture Capital investment in Series B - Veritas In Silico
Shinsei Corporate Investment
Shinsei Corporate Investment investment in Series A - Veritas In Silico
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series A - Veritas In Silico
Official Site Inspections
http://www.veritasinsilico.com Semrush global rank: 2.34 M Semrush visits lastest month: 8.37 K
- Host name: www3098.sakura.ne.jp
- IP address: 49.212.207.108
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "Veritas In Silico"
ABOUT | Veritas In Silico Inc.
Veritas In Silico is unveiling the mysteries of RNA and harnessing the potential of messenger RNA (mRNA) as a drug target. Powered by our proprietary in silico technology, we have established an entirely new system for drug discovery …See details»
Veritas In Silico Inc.
2024.06.19 Veritas In Silico Announces Milestone Achievement in Collaborative Research with Takeda; 2024.02.08 Veritas In Silico Listed on the Growth Market of the Tokyo Stock Exchange; 2023.12.21 RaQualia Pharma and Veritas In …See details»
Veritas In Silico Inc. - HOME
Veritas In Silico Inc. ("VIS," Head Office: Shinagawa-ku, Tokyo; Representative Director: Shingo Nakamura) announced today the launch of its joint research with Teijin Pharma Limited ("Teijin …See details»
Veritas In Silico - Crunchbase Company Profile & Funding
Veritas In Silico is a research and sales of pharmaceuticals firm that offers drug discovery platform technology with scientific evidences.See details»
株式会社Veritas In Silico
2024.06.19 Veritas In Silico、武田薬品との共同創薬研究の進展に伴うマイルストーン達成のお知らせ; 2024.02.08 東京証券取引所グロース市場への上場のお知らせ; 2024.01.31 発行価格及び売出価格の決定並びにオーバーアロットメント …See details»
Veritas In Silico Inc. | LinkedIn
Veritas In Silico is unveiling the mysteries of RNA and harnessing the potential of messenger RNA (mRNA) as a drug target. Powered by our proprietary in silico technology, we have established an...See details»
Veritas In Silico Inc. - VentureRadar
We provide a full platform for a complete cancer cure solution to detect, treat and monitor both solid tumor cancers and blood cancers using our unique targets and CAR immuno technology …See details»
Veritas In Silico - PitchBook
Mar 15, 2018 · Information on stock, financials, earnings, subsidiaries, investors, and executives for Veritas In Silico. Use the PitchBook Platform to explore the full profile.See details»
Veritas In Silico - Products, Competitors, Financials, Employees ...
Feb 8, 2024 · Veritas In Silico is a biotechnology company focused on the discovery of drugs that target messenger RNA within the pharmaceutical industry. The company serves the …See details»
Financial Results | Veritas In Silico Inc.
The latest version of Adobe Acrobat Reader is required to view PDF files. Adobe Acrobat Reader is available as a free download from the website of Adobe Systems.See details»
Veritas In Silico Inc. - NEWS
Veritas In Silico's proprietary in silico technology enables the identification of druggable motifs with high existence probabilities on the mRNA, and its high-throughput assay allows for the …See details»
株式会社Veritas In Silico - YouTube
Mar 6, 2022 · 核酸を創薬標的として中低分子創薬を行い、新たな治療法の実現を目指す株式会社Veritas In Silicoの紹介動画です。 ホームページ：https://www.veritasinsilico.com/See details»
Veritas In Silico中村社長「特化型医薬品メーカーに転換」 経営 …
Feb 8, 2024 · 体内のメッセンジャーRNA（mRNA）を標的とした低分子治療薬を開発するVeritas In Silico（ウェリタス ・イン・シリコ）が8日、東証グロースに上場した。 初値は公開価 …See details»
中村 慎吾 | Veritas In Silico｜note
株式会社Veritas In Silico 代表取締役社長。当社の取り組みや将来的に目指すビジネス等について、中村の思いを語ります。 LinkedIn: https://www.linkedin.com/company/veritasinsilico/See details»
PLATFORM | Veritas In Silico Inc.
Behind Veritas In Silico’s platform technologies is a team of RNA experts, including academics who lead the fields of RNA structural and computational biology, RNA-targeted small molecule …See details»
株式会社Veritas In Silicoの会社情報と資金調達 | NIKKEI COMPASS …
Mar 9, 2023 · 株式会社Veritas In Silico Veritas In Silico Inc. 【創薬ベンチャー】メッセンジャーRNAを標的にした新薬を開発。 製薬企業とも提携。See details»
株式会社Veritas In Silico - お知らせ
VISはシリーズA期間中、独自の核酸構造解析技術により、核酸を標的とした中分子医薬品のパイプライン創出（中分子創薬事業）を目指してまいりました。 今回のシリーズBの資金調達に …See details»
Press Release | Veritas In Silico Inc.
2024.06.19 Veritas In Silico Announces Milestone Achievement in Collaborative Research with Takeda; 2024.02.08 Veritas In Silico Listed on the Growth Market of the Tokyo Stock …See details»
Veritasinsilico Cyber Security Rating & Vendor Risk Report ...
View Veritasinsilico's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving Veritasinsilico.See details»
Introduction to Veritas In Silico
Why partner with Veritas In Silico?See details»